Login with your work email address to view charts. No credit card required.
| Art Unit: | 1624 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1620 — Biomedicinal Chemistry |
| Classes: |
514 — Drug, bio-affecting and body treating compositions 540 — Organic compounds -- part of the class 532-570 series 544 — Organic compounds -- part of the class 532-570 series 424 — Drug, bio-affecting and body treating compositions 546 — Organic compounds -- part of the class 532-570 series 548 — Organic compounds -- part of the class 532-570 series 549 — Organic compounds -- part of the class 532-570 series 435 — Chemistry: molecular biology and microbiology 530 — Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof 558 — Organic compounds -- part of the class 532-570 series |
| Phone: | Available with subscription |
| Email: | Available with subscription |
| Title: | Pat Examnr Gen Chem |
| Service: | 30 years |
| Grade: | GS-14 |
| 3-Year Grant rate: | 83% over 671 cases |
|---|---|
| Difficulty: | Easier |
| Difficulty Percentile: | 38th
|
With Examiner Coleman, you have a 83% chance of getting an issued patent by 3 years after the first office action. Examiner Coleman is an easier examiner and in the 38th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Coleman, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Coleman's grant rate is higher than that of Art Unit 1624 and higher than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Coleman | 1.5 |
| Art Unit 1624 | 1.3 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.